Swiss National Bank’s West Pharmaceutical WST Stock Holding History

Swiss National Bank’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.9M	Buy	211,160 +14,120	+7%	+$3.51M	0.03%	426
2025 Q4	$54.2M	Sell	197,040 -10,060	-5%	-$2.75M	0.03%	408
2025 Q3	$54.3M	Sell	207,100 -11,700	-5%	-$2.84M	0.03%	411
2025 Q2	$47.9M	Buy	218,800 +14,600	+7%	+$3.12M	0.03%	443
2025 Q1	$45.7M	Sell	204,200 -700	-0.3%	-$193K	0.03%	429
2024 Q4	$67.1M	Sell	204,900 -11,600	-5%	-$3.65M	0.04%	340
2024 Q3	$65M	Sell	216,500 -200	-0.1%	-$61.3K	0.04%	361
2024 Q2	$71.4M	Sell	216,700 -4,900	-2%	-$1.73M	0.05%	326
2024 Q1	$87.7M	Sell	221,600 -9,400	-4%	-$3.48M	0.06%	289
2023 Q4	$81.3M	Sell	231,000 -7,800	-3%	-$2.76M	0.06%	297
2023 Q3	$89.6M	Sell	238,800 -29,400	-11%	-$11.4M	0.07%	269
2023 Q2	$103M	Sell	268,200 -25,600	-9%	-$9.15M	0.07%	275
2023 Q1	$102M	Sell	293,800 -7,100	-2%	-$2.07M	0.07%	283
2022 Q4	$70.8M	Sell	300,900 -20,075	-6%	-$4.76M	0.05%	357
2022 Q3	$79M	Sell	320,975 -1,200	-0.4%	-$366K	0.06%	324
2022 Q2	$97.4M	Buy	322,175 +1,300	+0.4%	+$423K	0.07%	286
2022 Q1	$132M	Buy	320,875 +39,700	+14%	+$15.5M	0.07%	256
2021 Q4	$132M	Sell	281,175 -10,700	-4%	-$4.61M	0.08%	243
2021 Q3	$124M	Sell	291,875 -10,600	-4%	-$4.47M	0.08%	240
2021 Q2	$109M	Sell	302,475 -12,525	-4%	-$4.14M	0.07%	287
2021 Q1	$88.8M	Buy	315,000 +36,100	+13%	+$10.3M	0.06%	322
2020 Q4	$79M	Sell	278,900 -7,600	-3%	-$2.13M	0.06%	331
2020 Q3	$78.8M	Sell	286,500 -5,700	-2%	-$1.51M	0.06%	302
2020 Q2	$66.4M	Buy	292,200 +5,200	+2%	+$1.02M	0.06%	328
2020 Q1	$43.7M	Buy	287,000 +54,300	+23%	+$8.36M	0.05%	378
2019 Q4	$35M	Buy	232,700 +94,400	+68%	+$13.7M	0.04%	468
2019 Q3	$19.6M	Buy	138,300 +300	+0.2%	+$41.3K	0.02%	578
2019 Q2	$17.3M	Buy	138,000 +3,000	+2%	+$354K	0.02%	609
2019 Q1	$14.9M	Buy	135,000 +5,000	+4%	+$520K	0.02%	632
2018 Q4	$12.7M	Buy	130,000 +1,000	+0.8%	+$109K	0.02%	617
2018 Q3	$15.9M	Hold	129,000	–	–	0.02%	619
2018 Q2	$12.8M	Hold	129,000	–	–	0.01%	652
2018 Q1	$11.4M	Buy	129,000 +3,000	+2%	+$281K	0.01%	664
2017 Q4	$12.4M	Buy	126,000 +3,000	+2%	+$294K	0.01%	654
2017 Q3	$11.8M	Buy	123,000 +1,000	+0.8%	+$90.5K	0.01%	652
2017 Q2	$11.5M	Buy	122,000 +1,100	+0.9%	+$101K	0.01%	652
2017 Q1	$9.87M	Buy	120,900 +500	+0.4%	+$41.8K	0.01%	682
2016 Q4	$10.2M	Buy	120,400 +2,200	+2%	+$173K	0.02%	645
2016 Q3	$8.81M	Sell	118,200 -2,400	-2%	-$191K	0.01%	669
2016 Q2	$9.15M	Buy	120,600 +1,200	+1%	+$87.3K	0.01%	665
2016 Q1	$7.99M	Buy	119,400 +25,500	+27%	+$1.53M	0.01%	683
2015 Q4	$5.66M	Hold	93,900	–	–	0.01%	739
2015 Q3	$5.08M	Buy	93,900 +12,400	+15%	+$723K	0.01%	771
2015 Q2	$4.73M	Buy	81,500 +1,900	+2%	+$106K	0.01%	796
2015 Q1	$4.79M	Buy	79,600 +1,000	+1%	+$53.3K	0.01%	802
2014 Q4	$4.18M	Buy	78,600 +1,800	+2%	+$90K	0.02%	800
2014 Q3	$3.44M	Sell	76,800 -1,000	-1%	-$42.5K	0.01%	892
2014 Q2	$3.28M	Hold	77,800	–	–	0.01%	950
2014 Q1	$3.43M	Buy	77,800 +17,300	+29%	+$814K	0.01%	897
2013 Q4	$2.97M	Sell	60,500 -8,500	-12%	-$398K	0.01%	841
2013 Q3	$2.84M	Buy	69,000 +6,200	+10%	+$237K	0.01%	816
2013 Q2	$2.21M	Buy	+62,800	New	+$2.07M	0.01%	931